Welcome!

Agile Computing Authors: Pat Romanski, Elizabeth White, Yeshim Deniz, Liz McMillan, Andy Thurai

News Feed Item

Actress Rose McGowan To Appear On TV's The Doctors To Speak Out About Pulmonary Fibrosis, Disease That Killed Her Father

Actress Leads Awareness Activities for Coalition for Pulmonary Fibrosis' Daughters of PF program

HOLLYWOOD, Calif., Dec. 12, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis announced today motion picture and television actress Rose McGowan will be a guest on Friday, December 14th on CBS TV's The Doctors.  She will share her tragic personal story of how she watched her father suffer and die from the incurable lung disease, Pulmonary Fibrosis (PF) and help raise awareness of the disease that kills as many Americans as breast cancer each year To view local TV listings for the show, visit:  http://www.thedoctorstv.com

"Pulmonary Fibrosis is a horrible, horrible way to go," said Rose McGowan. "It makes me quite angry that not a lot of people know about it.  I want to help change that."

Perhaps best known for her roles on TV's long-running, Charmed, and the 2011 motion picture, Conan the Barbarian, among others,  McGowan lost her father, artist Daniel McGowan, in 2009 to PF. PF has no cure and no FDA-approved treatments and causes uncontrollable and irreversible scarring in the lung tissue, causing its victims to suffocate. 

McGowan is taking a lead role in the effort build awareness to fight the disease and is working closely with the CPF, a non-profit foundation.

As CPF's Ambassador and Chair of The Daughters of PF program, McGowan is  helping generate wide public awareness about PF, which has thus far been little known to the broad U.S. public. In so doing, she intends to use her celebrity to shine a spotlight on PF, much as other prominent individuals have done for diseases such as AIDS, breast cancer, Parkinson's, and others.   

"We are honored that Rose is stepping in front of this cause and speaking out and helping give patients and families a voice in fighting this horrible disease," said Mishka Michon, CEO of the Coalition for Pulmonary Fibrosis.  "Because she has been directly affected by PF through her father's illness and death, she has a unique perspective and personally understands the plight of patients and their families. Her efforts will contribute to forever changing the landscape for this little known killer and will also help find successful treatments and eventually a cure." 

To learn more about the CPF and its Daughters of PF, visit www.coalitionforpf.org or their Facebook page.    

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring – known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis.  Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About Daughters of PF

In 2011, the Coalition for Pulmonary Fibrosis launched a new effort inspired by the tens of thousands of daughters (and others) who have seen a parent suffer from PF.  The women involved in Daughters of PFare professional women in various fields and specialties including legal, medical, and educational.  The women are creating projects across the country and in their local areas to increase awareness and understanding of PF and also holding fundraisers to raise needed money for research and patient support services.  Their efforts are reflective of their interests and talents and will allow them to make a difference right where they are.  For more information, contact the CPF at [email protected] or call 1-888-222-8541, ext. 702. 

About the CPF

The CPF is a 501C(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 26,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.

SOURCE Coalition for Pulmonary Fibrosis

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
The Founder of NostaLab and a member of the Google Health Advisory Board, John is a unique combination of strategic thinker, marketer and entrepreneur. His career was built on the "science of advertising" combining strategy, creativity and marketing for industry-leading results. Combined with his ability to communicate complicated scientific concepts in a way that consumers and scientists alike can appreciate, John is a sought-after speaker for conferences on the forefront of healthcare science,...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
DXWorldEXPO LLC announced today that Ed Featherston has been named the "Tech Chair" of "FinTechEXPO - New York Blockchain Event" of CloudEXPO's 10-Year Anniversary Event which will take place on November 12-13, 2018 in New York City. CloudEXPO | DXWorldEXPO New York will present keynotes, general sessions, and more than 20 blockchain sessions by leading FinTech experts.
Apps and devices shouldn't stop working when there's limited or no network connectivity. Learn how to bring data stored in a cloud database to the edge of the network (and back again) whenever an Internet connection is available. In his session at 17th Cloud Expo, Ben Perlmutter, a Sales Engineer with IBM Cloudant, demonstrated techniques for replicating cloud databases with devices in order to build offline-first mobile or Internet of Things (IoT) apps that can provide a better, faster user e...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science" is responsible for guiding the technology strategy within Hitachi Vantara for IoT and Analytics. Bill brings a balanced business-technology approach that focuses on business outcomes to drive data, analytics and technology decisions that underpin an organization's digital transformation strategy.
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...